Skip to main content

Table 3 Laboratory findings of the studied patients

From: Role of shear wave elastography in characterization of hepatic focal lesions

Lab investigations

Benign lesions, N = 28 (25.45%)

Malignant lesions, N = 82 (74.54%)

χ2

p value

CBC

RBCS (mean ± SD)

4.7 ± 0.23

4.5 ± 0.52

0.751

0.420

WBCS (mean ± SD)

5876.2 ± 911.2

5395.1 ± 1037.1

1.56

0.120

Platelets (mean ± SD)

250.3 ± 39.4

198.2 ± 67.23

2.745

0.009

Virology

Negative

10 (71.4%)

2 (4.9%)

27.65

0.001

Hepatitis B

1 (7.1%)

11 (26.8%)

Hepatitis C

3 (21.4%)

28 (68.3%)

Liver functions

Bilirubin (mean ± SD)

1.23 ± 1.67

2.06 ± 3.6

0.751

0.411

Albumin (mean ± SD)

3.9 ± 0.2

3.52 ± 0.54

2.641

0.013

SGOT (mean ± SD)

38.32 ± 12.35

57.32 ± 23.10

2.832

0.006

SGPT (mean ± SD)

39.1 ± 14.20

56.32 ± 16.14

3.214

0.002

Renal functions

Creatinine (mean ± SD)

3.9 ± 1.20

1.2 ± 0.21

1.652

0.095

Urea (mean ± SD)

32.1 ± 6.25

37.2 ± 5.64

2.741

0.008

INR

(mean ± SD)

0.91 ± 0.07

0.97 ± 0.17

0.851

0.376

PC

(mean ± SD)

75.2 ± 5.12

72.4 ± 8.32

0.941

0.351

Tumor markers

AFP (mean ± SD)

22.1 ± 14.32

504.32 ± 387.1

4.651

0.001